Duan Z - Search Results

1

Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.

Liu X, Gao Y, Shen J, Yang W, Choy E, Mankin H, Hornicek FJ, Duan Z. Liu X, et al. Among authors: duan z. Mol Cancer Ther. 2016 Jul;15(7):1691-701. doi: 10.1158/1535-7163.MCT-16-0032. Epub 2016 May 20. Mol Cancer Ther. 2016. PMID: 27207777 Free PMC article.

2

Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.

Lamendola DE, Duan Z, Yusuf RZ, Seiden MV. Lamendola DE, et al. Among authors: duan z. Cancer Res. 2003 May 1;63(9):2200-5. Cancer Res. 2003. PMID: 12727840

3

Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.

Duan Z, Brakora KA, Seiden MV. Duan Z, et al. Mol Cancer Ther. 2004 Jul;3(7):833-8. Mol Cancer Ther. 2004. PMID: 15252144

4

Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.

Duan Z, Lamendola DE, Duan Y, Yusuf RZ, Seiden MV. Duan Z, et al. Among authors: duan y. Cancer Chemother Pharmacol. 2005 Mar;55(3):277-85. doi: 10.1007/s00280-004-0878-y. Epub 2004 Nov 24. Cancer Chemother Pharmacol. 2005. PMID: 15565326

5

GBP1 overexpression is associated with a paclitaxel resistance phenotype.

Duan Z, Foster R, Brakora KA, Yusuf RZ, Seiden MV. Duan Z, et al. Cancer Chemother Pharmacol. 2006 Jan;57(1):25-33. doi: 10.1007/s00280-005-0026-3. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16028104

6

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.

Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Duan Z, et al. Clin Cancer Res. 2006 Sep 1;12(17):5055-63. doi: 10.1158/1078-0432.CCR-06-0861. Clin Cancer Res. 2006. PMID: 16951221

7

Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.

van Vlerken LE, Duan Z, Seiden MV, Amiji MM. van Vlerken LE, et al. Among authors: duan z. Cancer Res. 2007 May 15;67(10):4843-50. doi: 10.1158/0008-5472.CAN-06-1648. Cancer Res. 2007. PMID: 17510414

8

8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.

Duan Z, Bradner J, Greenberg E, Mazitschek R, Foster R, Mahoney J, Seiden MV. Duan Z, et al. Mol Pharmacol. 2007 Nov;72(5):1137-45. doi: 10.1124/mol.107.038117. Epub 2007 Aug 3. Mol Pharmacol. 2007. PMID: 17675586

9

CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.

Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, Seiden MV. Duan Z, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):681-9. doi: 10.1007/s00280-008-0785-8. Epub 2008 Jun 28. Cancer Chemother Pharmacol. 2009. PMID: 18587580 Free PMC article.

10

Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model.

van Vlerken LE, Duan Z, Little SR, Seiden MV, Amiji MM. van Vlerken LE, et al. Among authors: duan z. Mol Pharm. 2008 Jul-Aug;5(4):516-26. doi: 10.1021/mp800030k. Epub 2008 Jul 11. Mol Pharm. 2008. PMID: 18616278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,028 results

Search Page

Filters